{"DataElement":{"publicId":"7155078","version":"1","preferredName":"Ancillary Study Ki-67 Labeling Index Integer","preferredDefinition":"An integer number between 0 and 100 to capture the percentage of cells in a sample that are dividing as determined by immunohistochemical staining techniques using MIB-1 antibody (anti-Ki-67 protein antibody.","longName":"7113142v1.0:6847952v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7113142","version":"1","preferredName":"Ancillary Study Ki-67 Labeling Index","preferredDefinition":"A study that is secondary to another study._The percentage of cells in a sample that are dividing that is determined by immunohistochemical staining techniques using MIB-1 antibody (anti-Ki-67 protein antibody).","longName":"7052721v1.0:7113140v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7052721","version":"1","preferredName":"Ancillary Study","preferredDefinition":"A study that is secondary to another study.","longName":"C16041","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ancillary Study","conceptCode":"C16041","definition":"A study that is secondary to another study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"973C983C-51FC-1152-E053-F662850AE6FF","latestVersionIndicator":"Yes","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-13","modifiedBy":"ONEDATA","dateModified":"2019-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7113140","version":"1","preferredName":"Ki-67 Labeling Index","preferredDefinition":"The percentage of cells in a sample that are dividing that is determined by immunohistochemical staining techniques using MIB-1 antibody (anti-Ki-67 protein antibody).","longName":"C157250","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ki-67 Labeling Index","conceptCode":"C157250","definition":"The percentage of cells in a sample that are dividing that is determined by immunohistochemical staining techniques using MIB-1 antibody (anti-Ki-67 protein antibody).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A7A7A99-77DA-653A-E053-F662850A616C","latestVersionIndicator":"Yes","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A7A7A99-77EB-653A-E053-F662850A616C","latestVersionIndicator":"Yes","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"KNABLEJ","dateModified":"2020-05-14","changeDescription":"5/14/20 jk Released per SME (NGM) review and approval email.  12/24/19 jk created for CPTAC LGG baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6847952","version":"1","preferredName":"Integer","preferredDefinition":"A positive number with no fractional part between 0 and 100.","longName":"6847952v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"Integer","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433737","version":"1","preferredName":"Integer","preferredDefinition":"A number with no fractional part.","longName":"C45255","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4769-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-25","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-25","modifiedBy":"ONEDATA","dateModified":"2005-11-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F867DFE-8763-5C6C-E053-F662850A9F8B","latestVersionIndicator":"Yes","beginDate":"2019-08-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-08-07","modifiedBy":"KNABLEJ","dateModified":"2020-01-22","changeDescription":"1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set.  8/7/19 jk created for CPTAC baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6779545","version":"1","longName":"LGG Local Pathology","context":"OCCPR"},{"publicId":"6779546","version":"1","longName":"LGG Pathology Review","context":"OCCPR"},{"publicId":"6601275","version":"1","longName":"Brain","context":"OCCPR"},{"publicId":"6779544","version":"1","longName":"LGG Baseline","context":"OCCPR"}]},{"publicId":"6705584","version":"1","longName":"CCG PTCL (Center for Cancer Genomics - Peripheral T Cell Lymphoma)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"7715738","version":"1","longName":"HOPE-CARE","context":"NCIP"}]}],"AlternateNames":[{"name":"NCIP","type":"USED_BY","context":"NCIP"},{"name":"mib1_score","type":"Context Short Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Ki-67 / MIB1 Labeling Index","type":"Preferred Question Text","description":"Ki-67 / MIB1 Labeling Index","url":null,"context":"OCCPR"},{"name":"MIB-1 (Ki-67) index/score","type":"Alternate Question Text","description":"MIB-1 (Ki-67) index/score","url":null,"context":"NCIP"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9D4837C8-C5C7-3CA2-E053-F662850A33D6","latestVersionIndicator":"Yes","beginDate":"2020-01-29","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-29","modifiedBy":"KUMMEROA","dateModified":"2021-07-14","changeDescription":"20217-6 ak Added context alt short name. 5/14/20 jk Released per SME (NGM) review and approval email.  4/30/20 jk added CPTAC LGG Path CSI. 1/29/20 jk created for CPTAC LGG baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}